Three common medical conditions may explain why some heavy drinkers develop advanced liver disease while others do not, ...

The increasing prevalence of chronic conditions like cardiovascular disease is driving the demand for transmucosal drugs. Key factors contributing to the transmucosal drugs market's growth from ...

The namesake WtP is maintained for consistency. Our new followup SaT provides robust, efficient and adaptable sentence segmentation across 85 languages at higher performance and less compute cost.

Drinking alcohol significantly increases the risk of advanced liver disease in people with diabetes, high blood pressure, or ...

Providing deeper insights, analysts have established 12-month price targets, indicating an average target of $58.6, along ...

If you've got a big belly, diabetes or high blood pressure, you may want to limit your alcohol, experts warn, as dri ...

Research reveals semaglutide's effectiveness in decreasing alcohol consumption and cravings, highlighting its potential for ...

“Saturday Night Live” was built with a cast of young no-names performing countercultural comedy. Fifty years later, it is ...

The Type C meeting follows the recent public workshop led by the PARASOL (Proteinuria and GFR as Clinical Trial Endpoints in Focal Segmental Glomerulosclerosis ... in up to 3.5% of FILSPARI-treated ...

Company completed Type C meeting with FDA, aligning on its plan to submit an sNDA; submission expected around end of 1Q25If approved, FILSPARI ...

Gilead Sciences faces revenue growth challenges as its blockbuster drugs lose exclusivity by 2033. Check out my ...

Drinking alcohol if you have a large belly or diabetes more than doubles the risk of serious liver damage, while having high ...